Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02889835 · ClinicalTrials.gov registry record · NA
Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations
A NA study of Dental Caries, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT02889835: Completed NA study of Dental Caries, sponsored by Solventum US.
NCT02889835 is a NA study of Dental Caries that has completed, run by Solventum US. The registered enrollment target is 53 participants, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02889835, a NA study of Dental Caries, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the clinical performance of Class II restorations over a three year period with 3 composite resins - a conventional composite resin, a flowable composite resin and a bulk placed and cured composite resin.
Primary Outcome
Percentage of restorations that survived (percent clinically acceptable per FDI criteria) over 36 months.
Conditions Studied
Interventions
- DEVICE Supreme Universal Restorative
- DEVICE Supreme Flowable Restorative
- DEVICE Bulk Fill Flowable Restorative
Study Locations (1)
Alabama
- University of Alabama at Birmingham Dental School - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-03-22 |
| Est. Completion | 2021-07-03 |
| Phase | NA |
What the finished NCT02889835 record still lists
NCT02889835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 3 interventions - of which Supreme Universal Restorative is the first listed.
NCT02889835 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02889835 about?
NCT02889835 is a clinical study titled "Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations". This study will examine the clinical performance of Class II restorations over a three year period with 3 composite resins - a conventional composite resin, a flowable composite resin and a bulk placed and cured composite resin.
What is the current status of trial NCT02889835?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2016-03-22. Estimated completion is 2021-07-03.
What conditions does trial NCT02889835 study?
This clinical trial studies the following conditions: Dental Caries.
What interventions are being tested in trial NCT02889835?
The interventions under investigation include: Supreme Universal Restorative (DEVICE), Supreme Flowable Restorative (DEVICE), Bulk Fill Flowable Restorative (DEVICE).
Who is sponsoring clinical trial NCT02889835?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02889835 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02889835's enrollment target sits among peer trials
53 17th of 30 higher than 14 of 30 other Dental Caries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
RECRUITING · NA
-
LT Comparative Effectiveness of 2 Caries Treatments
RECRUITING · NA
-
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
RECRUITING · NA
-
In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI